
### [Orphanet:225713](http://www.orpha.net/ORDO/Orphanet_225713)
**Label:** Other metabolic disease with epilepsy

**Subclasses:** [Orphanet:71277](http://www.orpha.net/ORDO/Orphanet_71277) (Encephalopathy due to GLUT1 deficiency), [Orphanet:319651](http://www.orpha.net/ORDO/Orphanet_319651) (Constitutional megaloblastic anemia with severe neurologic disease), [Orphanet:2388](http://www.orpha.net/ORDO/Orphanet_2388) (Choreoacanthocytosis), [Orphanet:59306](http://www.orpha.net/ORDO/Orphanet_59306) (McLeod neuroacanthocytosis syndrome), [Orphanet:457375](http://www.orpha.net/ORDO/Orphanet_457375) (ITPA-related encephalopathy), 

**Corr. equiv. classes:** [Orphanet:2388](http://www.orpha.net/ORDO/Orphanet_2388), [Orphanet:457375](http://www.orpha.net/ORDO/Orphanet_457375), [Orphanet:59306](http://www.orpha.net/ORDO/Orphanet_59306), [OMIM:616647](http://purl.obolibrary.org/obo/OMIM_616647), [OMIM:606777](http://purl.obolibrary.org/obo/OMIM_606777), [OMIM:300842](http://purl.obolibrary.org/obo/OMIM_300842), [Orphanet:71277](http://www.orpha.net/ORDO/Orphanet_71277), [Orphanet:319651](http://www.orpha.net/ORDO/Orphanet_319651), [OMIM:200150](http://purl.obolibrary.org/obo/OMIM_200150), [OMIM:613839](http://purl.obolibrary.org/obo/OMIM_613839), 

**Class expressions from DL-Learner:**

- [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) and [HP:0100852](http://purl.obolibrary.org/obo/HP_0100852) (Abnormal fear/anxiety-related behavior) 65.00%
- [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) 65.00%
- [HP:0001260](http://purl.obolibrary.org/obo/HP_0001260) (Dysarthria) and [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) 65.00%
- [HP:0000739](http://purl.obolibrary.org/obo/HP_0000739) (Anxiety) and [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) 65.00%
- [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) and [HP:0100852](http://purl.obolibrary.org/obo/HP_0100852) (Abnormal fear/anxiety-related behavior) 65.00%
- [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) and [HP:0031466](http://purl.obolibrary.org/obo/HP_0031466) (Impairment in personality functioning) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) 65.00%
- [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) and [HP:0100852](http://purl.obolibrary.org/obo/HP_0100852) (Abnormal fear/anxiety-related behavior) 65.00%
- [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) and [HP:0031466](http://purl.obolibrary.org/obo/HP_0031466) (Impairment in personality functioning) 65.00%
- [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) and [HP:0100852](http://purl.obolibrary.org/obo/HP_0100852) (Abnormal fear/anxiety-related behavior) 65.00%
- [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) 65.00%
- [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) and [HP:0100852](http://purl.obolibrary.org/obo/HP_0100852) (Abnormal fear/anxiety-related behavior) 65.00%
- [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) 65.00%
- [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) and [HP:0031466](http://purl.obolibrary.org/obo/HP_0031466) (Impairment in personality functioning) 65.00%
- [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) and [HP:0011446](http://purl.obolibrary.org/obo/HP_0011446) (Abnormality of higher mental function) and [HP:0100852](http://purl.obolibrary.org/obo/HP_0100852) (Abnormal fear/anxiety-related behavior) 65.00%
- [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) and [HP:0011021](http://purl.obolibrary.org/obo/HP_0011021) (Abnormality of circulating enzyme level) and [HP:0100852](http://purl.obolibrary.org/obo/HP_0100852) (Abnormal fear/anxiety-related behavior) 65.00%


